These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 22750233)

  • 21. Interferon inhibits the replication of HIV-1, SIV, and SHIV chimeric viruses by distinct mechanisms.
    Korth MJ; Taylor MD; Katze MG
    Virology; 1998 Aug; 247(2):265-73. PubMed ID: 9705919
    [TBL] [Abstract][Full Text] [Related]  

  • 22. On the cell biology of HIV integration from basic research to development of novel antiviral drugs.
    Debyser Z; Christ F
    Verh K Acad Geneeskd Belg; 2010; 72(5-6):219-37. PubMed ID: 21409951
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Retinoic acid-inducible gene-I-like receptors and RNA virus recognition--a review].
    Qin C; Qin E
    Wei Sheng Wu Xue Bao; 2008 Oct; 48(10):1418-23. PubMed ID: 19160829
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Phosphorylation of Single Stranded RNA Virus Proteins and Potential for Novel Therapeutic Strategies.
    Keck F; Ataey P; Amaya M; Bailey C; Narayanan A
    Viruses; 2015 Oct; 7(10):5257-73. PubMed ID: 26473910
    [TBL] [Abstract][Full Text] [Related]  

  • 25. An AlphaScreen®-based assay for high-throughput screening for specific inhibitors of nuclear import.
    Wagstaff KM; Rawlinson SM; Hearps AC; Jans DA
    J Biomol Screen; 2011 Feb; 16(2):192-200. PubMed ID: 21297106
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Non-infectious plasmid engineered to simulate multiple viral threat agents.
    Carrera M; Sagripanti JL
    J Virol Methods; 2009 Jul; 159(1):29-33. PubMed ID: 19442841
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Structure-based antivirals for emerging and neglected RNA viruses: an emerging field for medicinal chemistry in academia.
    Hilgenfeld R
    Future Med Chem; 2010 Jul; 2(7):1061-7. PubMed ID: 21426155
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Antiviral (RNA) activity of selected Amaryllidaceae isoquinoline constituents and synthesis of related substances.
    Gabrielsen B; Monath TP; Huggins JW; Kefauver DF; Pettit GR; Groszek G; Hollingshead M; Kirsi JJ; Shannon WM; Schubert EM
    J Nat Prod; 1992 Nov; 55(11):1569-81. PubMed ID: 1336040
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Encephalitis due to emerging viruses: CNS innate immunity and potential therapeutic targets.
    Denizot M; Neal JW; Gasque P
    J Infect; 2012 Jul; 65(1):1-16. PubMed ID: 22484271
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Review of antiviral peptides for use against zoonotic and selected non-zoonotic viruses.
    Hollmann A; Cardoso NP; Espeche JC; Maffía PC
    Peptides; 2021 Aug; 142():170570. PubMed ID: 34000327
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Nuclear traffic of influenza virus proteins and ribonucleoprotein complexes.
    Boulo S; Akarsu H; Ruigrok RW; Baudin F
    Virus Res; 2007 Mar; 124(1-2):12-21. PubMed ID: 17081640
    [TBL] [Abstract][Full Text] [Related]  

  • 32. S-nitrosylation of viral proteins: molecular bases for antiviral effect of nitric oxide.
    Colasanti M; Persichini T; Venturini G; Ascenzi P
    IUBMB Life; 1999 Jul; 48(1):25-31. PubMed ID: 10791912
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The strategy of RNA viruses.
    Baltimore D
    Harvey Lect; 1974-1975; 70 Series():57-74. PubMed ID: 4377923
    [No Abstract]   [Full Text] [Related]  

  • 34. Inhibition of RNA virus infections with peptide-conjugated morpholino oligomers.
    Stein DA
    Curr Pharm Des; 2008; 14(25):2619-34. PubMed ID: 18991679
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Role of Host-Mediated Post-Translational Modifications (PTMs) in RNA Virus Pathogenesis.
    Kumar R; Mehta D; Mishra N; Nayak D; Sunil S
    Int J Mol Sci; 2020 Dec; 22(1):. PubMed ID: 33396899
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Viral subversion of nucleocytoplasmic trafficking.
    Yarbrough ML; Mata MA; Sakthivel R; Fontoura BM
    Traffic; 2014 Feb; 15(2):127-40. PubMed ID: 24289861
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A focus on RNA viruses.
    Woodland DL
    Viral Immunol; 2011 Apr; 24(2):67-8. PubMed ID: 21449716
    [No Abstract]   [Full Text] [Related]  

  • 38. Drug delivery system to control infectious diseases.
    Shoji Y; Shimada J; Mizushima Y
    Curr Pharm Des; 2002; 8(6):455-65. PubMed ID: 12069382
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Natural Products with Potential to Treat RNA Virus Pathogens Including SARS-CoV-2.
    Christy MP; Uekusa Y; Gerwick L; Gerwick WH
    J Nat Prod; 2021 Jan; 84(1):161-182. PubMed ID: 33352046
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The nucleolar interface of RNA viruses.
    Rawlinson SM; Moseley GW
    Cell Microbiol; 2015 Aug; 17(8):1108-20. PubMed ID: 26041433
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.